Nicotine dependence and visceral adiposity as risk factors for the development and severity of carotid artery stenosis
- PMID: 37168312
- PMCID: PMC10165523
- DOI: 10.25122/jml-2022-0252
Nicotine dependence and visceral adiposity as risk factors for the development and severity of carotid artery stenosis
Abstract
Nicotine dependence (ND) and visceral adiposity are emerging as independent risk factors for cardiovascular diseases, including carotid artery stenosis (CAS). This study aimed to determine the relationship between ND and the contribution of abdominal fat to the onset of CAS, which is indicated by a luminal narrowing of at least 60% as determined by duplex and/or Doppler ultrasound. We prospectively collected data from 60 patients with CAS and 60 age- and gender-matched healthy subjects. The Fagerström Test for Nicotine Dependence (FTND), a common research tool, was used in the study. The original questionnaire was designed to gather social and demographic data. Anthropometric measurements, visceral adiposity index (VAI), and lipid accumulation products (LAP) were used to assess obesity. Most patients showed a high or mild-moderate degree of ND: 46.67% and 35%, respectively. The median visceral adiposity index (VAI) and lipid accumulation product (LAP) in patients was 3.92 and 32.83, respectively. Prolonged smoking duration, increased intensity, and high ND are hallmarks of CAS patients.
Keywords: BMI – Body Mass Index; CAS – Carotid Artery Stenosis; CVD – Cardiovascular Disease; DUS – Doppler ultrasound; IHD – Ischemic Heart Disease; LAP – Lipid Accumulation Products; VAI – Visceral Adiposity Index; WC – Waist Circumference; WHR – Weight, Waist-Hip Ratio; carotid artery stenosis; lipid accumulation product; nicotine dependence; visceral adiposity index.
©2023 JOURNAL of MEDICINE and LIFE.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
LIPID ACCUMULATION PRODUCT, VISCERAL ADIPOSITY INDEX, AND CHINESE VISCERAL ADIPOSITY INDEX AS MARKERS OF CARDIOMETABOLIC RISK IN ADULT GROWTH HORMONE DEFICIENCY PATIENTS: A CROSS-SECTIONAL STUDY.Endocr Pract. 2018 Jan;24(1):33-39. doi: 10.4158/EP-2017-0007. Epub 2017 Nov 16. Endocr Pract. 2018. PMID: 29144802
-
Sensitivity of various body indices and visceral adiposity index in predicting metabolic syndrome among Chinese patients with adult growth hormone deficiency.J Endocrinol Invest. 2017 Jun;40(6):653-661. doi: 10.1007/s40618-017-0621-2. Epub 2017 Feb 23. J Endocrinol Invest. 2017. PMID: 28233232 Free PMC article.
-
Visceral Adiposity Measurements, Metabolic and Inflammatory Profi le in Obese Patients with and Without Type 2 Diabetes Mellitus: A Crosssectional Analysis.Curr Diabetes Rev. 2017;13(1):11-18. doi: 10.2174/1573399812666151015115924. Curr Diabetes Rev. 2017. PMID: 26467189
-
Lipid accumulation product and visceral adiposity index are effective markers for identifying the metabolically obese normal-weight phenotype.Acta Diabetol. 2015 Oct;52(5):855-63. doi: 10.1007/s00592-015-0715-2. Epub 2015 Feb 19. Acta Diabetol. 2015. PMID: 25690647
-
Visceral adiposity and inflammatory bowel disease.Int J Colorectal Dis. 2021 Nov;36(11):2305-2319. doi: 10.1007/s00384-021-03968-w. Epub 2021 Jun 9. Int J Colorectal Dis. 2021. PMID: 34104989 Review.
Cited by
-
Body Fat and Visceral Fat Values in Spanish Healthcare Workers: Associated Variables.Nutrients. 2025 Feb 11;17(4):649. doi: 10.3390/nu17040649. Nutrients. 2025. PMID: 40004977 Free PMC article.
References
-
- Tanaka T, Kishi S, Ninomiya K, Tomii D, et al. Impact of abdominal fat distribution, visceral fat, and subcutaneous fat on coronary plaque scores assessed by 320-row computed tomography coronary angiography. Atherosclerosis. 2019 Aug;287:155–161. doi: 10.1016/j.atherosclerosis.2019.06.910. - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials